Need for consensus guidelines to standardise the assessment of germinal centres and other histopathological parameters in salivary gland tissue of patients with primary Sjögren's syndrome

Annals of the Rheumatic Diseases

Volumn 75, Issue 6, 2016, Pages

  Delli, Konstantina ^a   Haacke, Erlin A ^a   Ihrler, Stephan ^b   Van Der Vegt, Bert ^a   Vissink, Arjan ^a   Bootsma, Hendrika ^a   Spijkervet, Frederik K L ^a   Kroese, Frans G M ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b Laboratory for Dermatohistology and Oral Pathology   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONSENSUS; DISEASE ASSOCIATION; GERMINAL CENTER; HISTOPATHOLOGY; HUMAN; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PREDICTION; PRIORITY JOURNAL; SALIVARY GLAND; SALIVARY GLAND BIOPSY; SCORING SYSTEM; SJOEGREN SYNDROME; STANDARDIZATION;

GERMINAL CENTER; HUMANS; SALIVARY GLANDS; SJOGREN'S SYNDROME;

EID: 84963857296     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2016-209480     Document Type: Article

References (12)

1. Hillen MR, Barone F, van Roon JA, et al. Towards standardisation of histopathological assessments of germinal centres and lymphoid structures in primary Sjögren's syndrome. Ann Rheum Dis 2016;75:e31.
2. Delli K, Haacke EA, Kroese FGM, et al. Towards personalised treatment in primary Sjögren's syndrome: baseline parotid histopathology predicts responsiveness to rituximab treatment. Ann Rheum Dis 2016; Published Online First 12 Jan 2016. doi:10.1136/annrheumdis-2015-208304
3. Fisher BA, Brown RM, Bowman SJ, et al. A review of salivary gland histopathology in primary Sjögren's syndrome with a focus on its potential as a clinical trials biomarker. Ann Rheum Dis 2015;74:1645-50.
4. Risselada AP, Looije MF, Kruize AA, et al. The role of ectopic germinal centers in the immunopathology of primary Sjögren's syndrome: a systematic review. Semin Arthritis Rheum. 2013;42:368-76.
5. Bombardieri M, Barone F, Humby F, et al. Activation-induced cytidine deaminase expression in follicular dendritic cell networks and interfollicular large B cells supports functionality of ectopic lymphoid neogenesis in autoimmune sialoadenitis and MALT lymphoma in Sjögren's syndrome. J Immunol 2007;179:4929-38.
6. Theander E, Vasaitis L, Baecklund E, et al. Lymphoid organisation in labial salivary gland biopsies is a possible predictor for the development of malignant lymphoma in primary Sjögren's syndrome. Ann Rheum Dis 2011;70:1363-8.
7. Tan LH. A practical approach to the understanding and diagnosis of lymphoma: an assessment of the WHO classification based on immunoarchitecture and immuno-ontogenic principles. Pathology 2009;41:305-26.
8. Gommerman JL, Browning JL. Lymphotoxin/light, lymphoid microenvironments and autoimmune disease. Nat Rev Immunol 2003;3:642-55.
9. Jonsson MV, Skarsteine K. Follicular dendritic cells confirm lymphoid organization in the minor salivary glands of primary Sjögren's syndrome. J Oral Pathol Med 2008;37:515-52.
10. Moerman RV, Arends S, Meiners PM, et al. EULAR Sjogren's Syndrome Disease Activity Index (ESSDAI) is sensitive to show efficacy of rituximab treatment in a randomised controlled trial. Ann Rheum Dis 2014;73:472-4.
11. Pijpe J, Kalk WWI, Wal JE et al. Parotid gland biopsy compared with labial biopsy in the diagnosis of patients with primary Sjögren's syndrome. Rheumatology (Oxford) 2007;46:335-41.
12. Delli K, Haacke EA, Kroese FGM, et al. In primary Sjögren's syndrome high absolute numbers and proportions of B cells in parotid glands predict responsiveness to rituximab as defined by ESSDAI, but not by SSRI. Ann Rheum Dis 2016;75:e34.